A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

J. Mascarenhas; H. Kosiorek; J. Prchal; A. Yacoub; D. Berenzon; M. R. Baer; E. Ritchie; R. T. Silver; C. Kessler; E. Winton; M. C. Finazzi; A. Rambaldi; A. M. Vannucchi; D. Leibowitz; D. Rondelli; M. O. Arcasoy; R. Catchatourian; J. Vadakara; V. Rosti; E. Hexner; M. Kremyanskaya; L. Sandy; J. Tripodi; V. Najfeld; N. Farnoud; M. E. Salama; R. S. Weinberg; R. Rampal; J. D. Goldberg; Ruben Mesa; A. C. Dueck; R. Hoffman

doi:10.1038/s41375-019-0524-7

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

J. Mascarenhas, H. Kosiorek, J. Prchal, A. Yacoub, D. Berenzon, M. R. Baer, E. Ritchie, R. T. Silver, C. Kessler, E. Winton, M. C. Finazzi, A. Rambaldi, A. M. Vannucchi, D. Leibowitz, D. Rondelli, M. O. Arcasoy, R. Catchatourian, J. Vadakara, V. Rosti, E. HexnerM. Kremyanskaya, L. Sandy, J. Tripodi, V. Najfeld, N. Farnoud, M. E. Salama, R. S. Weinberg, R. Rampal, J. D. Goldberg, Ruben Mesa, A. C. Dueck, R. Hoffman

Research output: Contribution to journal › Letter

2 Scopus citations

Original language	English (US)
Journal	Leukemia
DOIs	https://doi.org/10.1038/s41375-019-0524-7
State	Accepted/In press - Jan 1 2019
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Cite this

Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., ... Hoffman, R. (Accepted/In press). A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Leukemia. https://doi.org/10.1038/s41375-019-0524-7

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. / Mascarenhas, J.; Kosiorek, H.; Prchal, J.; Yacoub, A.; Berenzon, D.; Baer, M. R.; Ritchie, E.; Silver, R. T.; Kessler, C.; Winton, E.; Finazzi, M. C.; Rambaldi, A.; Vannucchi, A. M.; Leibowitz, D.; Rondelli, D.; Arcasoy, M. O.; Catchatourian, R.; Vadakara, J.; Rosti, V.; Hexner, E.; Kremyanskaya, M.; Sandy, L.; Tripodi, J.; Najfeld, V.; Farnoud, N.; Salama, M. E.; Weinberg, R. S.; Rampal, R.; Goldberg, J. D.; Mesa, Ruben; Dueck, A. C.; Hoffman, R.

In: Leukemia, 01.01.2019.

Research output: Contribution to journal › Letter

Mascarenhas, J, Kosiorek, H, Prchal, J, Yacoub, A, Berenzon, D, Baer, MR, Ritchie, E, Silver, RT, Kessler, C, Winton, E, Finazzi, MC, Rambaldi, A, Vannucchi, AM, Leibowitz, D, Rondelli, D, Arcasoy, MO, Catchatourian, R, Vadakara, J, Rosti, V, Hexner, E, Kremyanskaya, M, Sandy, L, Tripodi, J, Najfeld, V, Farnoud, N, Salama, ME, Weinberg, RS, Rampal, R, Goldberg, JD, Mesa, R, Dueck, AC & Hoffman, R 2019, 'A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis', Leukemia. https://doi.org/10.1038/s41375-019-0524-7

Mascarenhas, J. ; Kosiorek, H. ; Prchal, J. ; Yacoub, A. ; Berenzon, D. ; Baer, M. R. ; Ritchie, E. ; Silver, R. T. ; Kessler, C. ; Winton, E. ; Finazzi, M. C. ; Rambaldi, A. ; Vannucchi, A. M. ; Leibowitz, D. ; Rondelli, D. ; Arcasoy, M. O. ; Catchatourian, R. ; Vadakara, J. ; Rosti, V. ; Hexner, E. ; Kremyanskaya, M. ; Sandy, L. ; Tripodi, J. ; Najfeld, V. ; Farnoud, N. ; Salama, M. E. ; Weinberg, R. S. ; Rampal, R. ; Goldberg, J. D. ; Mesa, Ruben ; Dueck, A. C. ; Hoffman, R. / A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. In: Leukemia. 2019.

@article{4c06f921597f47f6be54951cd9340c82,

title = "A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis",

author = "J. Mascarenhas and H. Kosiorek and J. Prchal and A. Yacoub and D. Berenzon and Baer, {M. R.} and E. Ritchie and Silver, {R. T.} and C. Kessler and E. Winton and Finazzi, {M. C.} and A. Rambaldi and Vannucchi, {A. M.} and D. Leibowitz and D. Rondelli and Arcasoy, {M. O.} and R. Catchatourian and J. Vadakara and V. Rosti and E. Hexner and M. Kremyanskaya and L. Sandy and J. Tripodi and V. Najfeld and N. Farnoud and Salama, {M. E.} and Weinberg, {R. S.} and R. Rampal and Goldberg, {J. D.} and Ruben Mesa and Dueck, {A. C.} and R. Hoffman",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41375-019-0524-7",

language = "English (US)",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

AU - Mascarenhas, J.

AU - Kosiorek, H.

AU - Prchal, J.

AU - Yacoub, A.

AU - Berenzon, D.

AU - Baer, M. R.

AU - Ritchie, E.

AU - Silver, R. T.

AU - Kessler, C.

AU - Winton, E.

AU - Finazzi, M. C.

AU - Rambaldi, A.

AU - Vannucchi, A. M.

AU - Leibowitz, D.

AU - Rondelli, D.

AU - Arcasoy, M. O.

AU - Catchatourian, R.

AU - Vadakara, J.

AU - Rosti, V.

AU - Hexner, E.

AU - Kremyanskaya, M.

AU - Sandy, L.

AU - Tripodi, J.

AU - Najfeld, V.

AU - Farnoud, N.

AU - Salama, M. E.

AU - Weinberg, R. S.

AU - Rampal, R.

AU - Goldberg, J. D.

AU - Mesa, Ruben

AU - Dueck, A. C.

AU - Hoffman, R.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85069946674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069946674&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0524-7

DO - 10.1038/s41375-019-0524-7

M3 - Letter

C2 - 31363161

AN - SCOPUS:85069946674

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -

Access to Document

10.1038/s41375-019-0524-7